In 2024, Gavi, the Vaccine Alliance, kicks off its replenishment campaign to finance its activities until 2030, with the aim of providing access to immunization against more than twenty diseases in the world.

At the same time, Gavi is launching the African Vaccine Manufacturing Accelerator (AVMA), which aims to promote African sovereignty in this area. To this day, vaccines produced in Africa only meet 1% of the continent’s needs.

To mark the launch of AVMA and Gavi’s investment opportunity, Focus 2030 provides information, facts and figures, campaigns and interviews with specialists to take stock of the progress made by the Alliance and the path to achieve SDG 3.

Analysis.